PDPN/CLEC-2轴以血造干细胞调节巨核细胞主导的方式调节巨核细胞亚型
Rikuto Nara1, Hinako Notoh1, Tomoyuki Sasaki2
1Graduate School of Health Sciences, Hokkaido University, Japan.
Thrombosis research
|November 30, 2024
概括
该PDPN/CLEC-2轴影响巨核细胞分化,促进造血干细胞调节亚型. 这种相互作用会影响骨髓环境中的巨核细胞增殖和血小板产生.
科学领域:
- 血液学 血液学 血液学
- 细胞生物学 细胞生物学
- 干细胞研究 干细胞研究
背景情况:
- 巨核细胞存在以下亚型:免疫歪曲 (LSP1+),HSC调节 (MYLK4+) 和血小板产生 (BMAL1+).
- 表达波多普拉宁 (PDPN) 的树皮细胞形成骨髓微环境,支持大核形成.
- 在巨核细胞原始体上的PDPN-CLEC-2相互作用驱动了增殖,但其对亚型分化的影响尚不清楚.
研究的目的:
- 研究PDPN/CLEC-2轴在巨核细胞亚型分化中的作用.
- 确定PDPN表达的树皮细胞如何影响巨核细胞的发育和血小板的产生.
主要方法:
- 已建立的永生PDPN表达和PDPN淘汰的 stromal 细胞系.
- 与PDPN WT或KO养细胞共培养的骨髓血液生成原体.
- 分析了巨核细胞数量,性,血小板数量和分型极化.
主要成果:
- 与PDPN WT养器的共同培养与KO养器 (8N-16N) 相比,增加了巨核细胞数量和球性 (16N-32N).
- 血小板产量减少了PDPN WT养者.
- PDPN WT养者促进了MYLK4+ (调节HSC的) 大细胞,并减少了BMAL1+ (产生血小板的) 大细胞.
结论:
- PDPN/CLEC-2轴是巨核细胞亚型分化的一个关键调节器.
- 这个轴有利于HSC调节巨核细胞的发展,而不是产生血小板的巨核细胞.
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:21Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:19Multipotency of Hematopoietic Stem Cells
3.0K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.0K
01:28Role of Hematopoietic Growth Factors
1.2K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.2K
01:21Hematopoiesis
5.1K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.1K